Advanced Intestinal Barrier Assessment (Plasma)

Precision Point Diagnostics’ Advanced IBA profile takes a deep dive into intestinal barrier function. Using a collection of innovative biomarkers, this test helps clinicians determine if their patients have intestinal permeability, or “leaky gut.” Intestinal permeability has been suggested as a root cause of autoimmune diseases, systemic inflammation, and food sensitivities. Healing the gut barrier is so pivotal for resolving chronic disease that if it isn’t addressed, other treatments will have little to no effect.

The Advanced IBA profile stands out for its unique, clinically relevant markers which tell a complex story about gut barrier health. Histamine and diamine oxidase (DAO) give information about histamine balance and gut mucosal health. Plasma Zonulin is a well-documented marker of intestinal tight junctions and is the preferred specimen for assessment. Lipopolysaccharides (LPS) are endotoxins produced by gram-negative bacteria. LPS antibodies give information about inflammation and intestinal permeability. Patients with allergies, food sensitivities, digestive symptoms, headache, cognitive decline, depression, and more can benefit from the Advanced IBA profile (see Table of Associated Symptoms and Conditions).

Based on the results of the Advanced IBA profile, clinicians can tailor specific treatment protocols for their patients and monitor progress over time. Protocols to improve intestinal permeability are not one-size-fits-all. The Advanced IBA profile helps to identify the root cause of barrier dysfunction so that treatment is speedy, cost-effective, and successful. Some patients need to address DAO and histamine balance. Others need to address root causes of Zonulin elevation or high LPS antibodies. With the Advanced IBA profile, you can pinpoint and treat the causes of intestinal permeability and get your patients back on the road to wellness.

*Now offering H. Pylori antigen as an add on to this test. Adding this antigen gives you the opportunity to find out of your patient has this common bacteria that may sometimes lead to ulcers or stomach cancers.